| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 246,674 | 204,689 | 210,299 | 237,001 | | Cost of Revenue | 101,552 | 177,626 | 134,021 | 288,900 | | | Gross Profit | 145,122 | 27,063 | 76,278 | (51,899) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 85,006 | (25,194) | 40,557 | (92,134) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 20,204 | 19,184 | 18,845 | 19,534 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 39,835 | 33,073 | 16,876 | 20,701 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 40,412 | 17,554 | 17,078 | 18,993 | | Earnings Before Interest And Taxes | 81,034 | 50,627 | 33,954 | 39,694 | | Interest Expense | 32,186 | 11,505 | 15,136 | 15,848 | | Income Before Tax | 48,848 | 39,122 | 18,818 | 23,846 | | Income Tax Expense | 542 | 8,916 | 3,800 | 821 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 49,016 | 30,206 | 15,018 | 23,025 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 48,306 | 30,206 | 15,018 | 23,025 | | Preferred Stock And Other Adjustments | (35) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $48,271 | $30,206 | $15,018 | $23,025 |
|
0.25% Nasdaq 
0.02%
Income Statement
